Lv3
300 积分 2021-03-03 加入
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
5小时前
待确认
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors
7天前
已完结
CAR T Cells and T-Cell Therapies for Cancer
7天前
已完结
Beyond the blood: expanding CAR T cell therapy to solid tumors
7天前
已完结
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
7天前
已完结
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
7天前
已完结
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
7天前
已完结
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
7天前
已完结
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
7天前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
10天前
已完结
皖公网安备34019202002308
